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Abstract
Purpose To investigate the prevalence of ocular
Demodex folliculorum (DF) in an Irish population. To
validate a modified Ocular Surface Disease Index
questionnaire and employ it to evaluate the relationship between dry eye symptoms and the presence of
DF.
Methods One hundred and fifty-six subjects were
enrolled in an epidemiological cross-sectional prevalence study. Each subject completed a novel questionnaire on ocular symptoms and was assessed for the
presence of DF. Data was analysed to assess prevalence and to search for significant links between each
symptom and DF.
Results An overall prevalence of 68% was found.
Total mean number of DF found on microscopic
examination was 3.83 mites per subject (range 0–25).
The presence of symptoms was higher among individuals with DF (P = 0.04). Itch was found to be the
symptom most significantly associated with the presence and number of DF (P = 0.025 and P = 0.035,
respectively). The questionnaire showed good internal
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consistency (Cronbach’s alpha; a [ 0.7) and good
reliability (Intra-class Correlation Co-efficient;
ICC [ 0.7). The sensitivity and specificity of a
positive symptom result using the questionnaire were
70.8% and 46.9%, respectively.
Conclusion There is a strong association between
the prevalence of DF and symptoms, in particular
itchy eyes. However, not all patients with DF will be
symptomatic. The newly developed questionnaire is a
reliable instrument for measuring change in symptoms
over a period of time and suitable for observing patient
reported outcomes in interventional treatment studies.
Keywords Demodex folliculorum  Prevalence  Dry
eye symptoms  Blepharitis

Introduction
Demodex folliculorum (DF) and Demodex brevis (DB)
are eight legged ectoparasites that reside in the
pilosebaceous units of human skin [1–5]. The mites
feed on epidermal skin cells and sebum and are,
therefore, most commonly found in areas rich in
sebaceous glands—cheeks, nose, chin and the periocular area [2, 4–6]. DF inhabits the eyelash follicles. It
uses its claws to scrape at the internal walls of the lash
follicles resulting in follicular distention, epithelial
hyperplasia
and
reactive
hyperkeratinisation

123

406

[3, 5, 7, 8]. It is suggested that this forms a translucent
cuff at the base of the lash [9]: cylindrical dandruff
(CD). It has also been proposed that CD is the result of
an inflammatory cicatrix formed from dead DF within
the follicle [10]. CD is considered a pathognomonic
sign for DF infestation of the eyelash follicles [11].
Studies suggest DB resides in the sebaceous glands
and contributes to meibomian gland dysfunction
(MGD) by causing granulomatous changes to the
glandular cells and also physically blocking the gland
resulting in an accumulation of meibum within the
duct [3, 5, 8]. Given the location of the mites on the
eyelids; DF appears to be associated with anterior
blepharitis and DB with MGD. The resulting eyelid
inflammation causes inflammatory proteins to be
released into the tear film causing ocular surface
inflammation and irritation [12, 13].
Various ocular abnormalities such as anterior
blepharitis, MGD, aqueous deficient and evaporative
dry eye share similar symptoms involving the ocular
surface; itch, irritation, redness, burning sensations
[7, 14, 15]. This creates a challenge for practitioners to
distinguish between each condition when screening
patients based on symptoms alone.
Another dilemma is that dry eye is a multifactorial
disease, and the symptoms of dry eye and ocular
surface disease fluctuate and often do not correlate
well with the degree of ocular signs present [16–19].
Symptoms and severity of symptoms may vary
according to the condition and time of day [20].
MGD and blepharitis are more commonly associated
with a foreign body sensation and sticky eyes in the
morning, while aqueous deficient dry eye appears to
get worse throughout the day [20]. DF and DB can
produce an inflammatory reaction on the ocular
surface [21]. Itching and crusting at the eyelid margin
are among the most common symptoms associated
with DF infestation [7, 15, 22, 23]. This is most likely
due to the presence of CD on the eyelash margin and
the movement of the mites across the surface of the
skin. As mites are most active at night [24], it could be
hypothesised that patients with DF infestation would
be more symptomatic at night or in the morning after
the mites have been most active. To try to better
understand the relationship between DF and symptoms, it is important for subjects to report on the
frequency and severity of them. This also applies to
functional vision such as reading, using a computer,
and environmental conditions known to exacerbate
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symptoms in certain ocular surface diseases, for
example, wind and air conditioning [20, 25].
Increasingly, patient reported outcomes (PROs) are
becoming an integral part of clinical trials [26, 27].
Monitoring PROs after treatment is a good way of
investigating the effect of treatment on the patient
[27]. In 2011, the International Workshop on Meibomian Gland Dysfunction discussed the increasing
importance of PROs in clinical trials. A recommendation was also made to attempt to identify specific
symptoms for specific conditions, as the difficulty in
distinguishing between symptoms of different anterior
abnormalities is an ever present challenge [28]. The
present questionnaire was developed and analysed to
assess the relationship between DF and dry eye
symptoms. The capacity for the questionnaire to be
used as a diagnostic screener for DF blepharitis and its
ability to assess change in symptoms over the course
of treatment was also evaluated.

Materials and methods
Ethics statement
This study was conducted under the Tenets of Helsinki
Declaration of Human Studies [29] after approval by
the Dublin Institute of Technology Research Ethics
Committee.
Examination
Subjects from the National Optometry Centre, local
catchment area, and staff and students of Dublin
Institute of Technology were invited to part-take in a
cross-sectional prevalence study for ocular DF. Inclusion criteria: C 18 years of age. Exclusion criteria:
subjects currently being treated for blepharitis or who
had used treatment in the past 6 months, active ocular
infection (excluding blepharitis) or ocular surgery
within the past 6 months. Each subject completed the
novel questionnaire and was assessed for the presence
of DF. Presence of DF was defined as: positive
sighting of DF on lash rotation and/or one or more DF
counted on microscopic examination. One eyelash
from each eyelid was first manipulated in clockwise
and counter-clockwise directions using a sterile forceps, to stimulate DF tails, if present, to emerge from
the lash follicle. Subsequently, the lash was epilated
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for microscopic examination. Currently, rotation of
the eyelash prior to epilation is not a standardised
technique. However, its use in visualising DF prior to
epilation has been utilised in previous studies [5, 30].
Furthermore, it has been highlighted that lash manipulation has the potential to provide an alternative
method to lash epilation for visualising DF in a clinical
setting, although further research is required at present
[31, 32]. Thus, epilation and microscopic examination
remain the recommended method for DF diagnosis
[7, 32]. Adult DF count was recorded using the
modified Coston method [11]. Data was analysed to
assess the overall prevalence of DF found, and to
search for significant links between each symptom and
the presence and quantity of DF.
Questionnaire development
The symptom questionnaire was styled on the validated OSDI symptom questionnaire (Attachment 1). It
has been suggested that altering an existing questionnaire may help increase sensitivity of the symptom
questionnaire for the diagnosis of MGD or blepharitis
[33]. The OSDI format was chosen, as it is has shown
good repeatability and validity for effectively measuring the severity of dry eye [34]. It is one of the most
commonly used symptom questionnaires administered
to subjects in DF related clinical trials [15, 35, 36], and
the scoring system utilised by OSDI is scored on scale
of 0–100 with higher scores indicating increased
severity of symptoms. Each item in the questionnaire
is graded on a 4-point Likert scale indicating frequency of the symptom in question; where 0 equals
none of the time, 1—some of the time, 2—half of the
time, 3—most of the time, and 4—all of the time. The
total OSDI score is calculated using the following
formula: [total symptom number (A) 9 25/number of
questions answered (B)] [34, 37]. As the formula takes
into consideration the number of questions answered,
it is possible to use the formula to get OSDI values for
each of the subscales [34]. Previous studies have also
combined questions from different subscales to produce separate subscores using the OSDI formula [38].
Lee et al. [36] modified the OSDI questionnaire by
adding questions relating to blepharitis (itchy eyes and
matter along the eyelid margin), to increase the
questionnaires’ sensitivity to detect DF. Similar to
Lee et al. [36], questions relating to itchy eyes and
particulate matter along the eyelid margin were added
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to the current questionnaire. Questions on blurred
vision and poor vision were removed from the
symptom subscale and replaced with symptom questions from other validated dry eye questionnaires;
McMonnies (dryness, burning), 5-item Dry Eye
Questionnaire (DEQ-5) (dryness, watery), Standard
Patient Evaluation of Eye Dryness (SPEED) (dryness,
burning sensation, watery eyes). Novel questions
(itchy eyes and red eyes) not found in previous dry
eye questionnaires were included due to the high
reports of such symptoms found in the literature
[7, 15]. Symptoms were analysed in three different
ways: the presence of symptoms, the total modified
OSDI score, and the severity of symptoms. The
presence of symptoms was defined as asymptomatic or
symptomatic (regardless of severity). The severity of
symptoms was graded from the total modified OSDI
symptom score as shown in Table 1 [34, 37, 39].
Questionnaire validation
Suitability for use is dependent on the questionnaire
being reliable and reproducible: that any change
detected by the instrument is real and not as a result
of poor repeatability [40]. The reliability and reproducibility of the questionnaire was measured in two
ways. First, the internal consistency of the questionnaire was assessed using Cronbach’s a. In keeping
with the literature, alpha value [ 0.7 was accepted
[41, 42]. Second, the intra-rater reliability was
assessed using intra-class correlation (ICC) [43] and
the test–retest method; P \ 0.4 signifies poor reliability, 0.4 B P C 0.75 signifies fair to good reliability
and P C 0.75 signifies excellent reliability [44].
It is necessary that the questionnaire is also
responsive and sensitive to change as a result of
treatment [40]. This was measured by conducting a
test–retest post-treatment for both a non-treatment
Table 1 Severity of symptoms in accordance with total
modified OSDI score
Grade

Modified OSDI score

G0: Asymptomatic

0–12

G1: Mild

13–22

G2: Moderate

23–32

G3: Severe

33–100
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group and a treatment group and comparing the mean
using a 2-tailed t test (P \ 0.05 significance).
To allow for comparison with previous methods of
validation of dry eye questionnaires, a factor analysis
was applied to the symptom section of the questionnaire to determine if subscales similar to the OSDI dry
eye questionnaire existed. Cronbach’s a was applied to
each subscale.
A receiver operating characteristics curve was
generated to determine the sensitivity of the symptom
questionnaire for the diagnosis of DF infestation at
each symptom grade.
Statistical analysis
Statistical analysis was performed using the mathematical programme IBM SPSS (ver. 24.0). All summarised continuous data was expressed as mean and
range. The data between categorical variables was
assessed using Chi square analysis (X2). Betweengroup data was assessed using the Student’s t test,
Mann–Whitney U test (MWU) and Kruskal–Wallis H
(K–W) test where appropriate. Spearman’s correlation
co-efficient (rs) was used to assess scaled and continuous variables.

Results
Questionnaire validation
One hundred and fifty-six subjects completed the
questionnaire once. Suitable subjects were invited to
enrol in a separate interventional DF study. Data
analysis is ongoing and will be discussed in a separate
paper upon completion. Fifty separate subjects completed the questionnaire twice for the test–retest
assessments.
Factor analysis was applied to results from the 156
participants (age: 45.18 ± 18.36 years, gender: male
n = 70; 45%, female n = 86; 55%) who filled out the
questionnaire at least once. Extraction method ‘principal axis factoring’ was chosen, as the data was nonparametrically distributed [45]. Factor analysis
showed three sub-scales for the questionnaire similar
to the OSDI questionnaire: ocular symptoms, vision
related function and environmental triggers [34]
(Table 2).
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Cronbach’s a was applied to each subscale and to
the questionnaire as a whole. Cronbach’s a for the
overall symptom questionnaire was good at 0.824,
each of the subscales had a slightly lower a value but
were still [ 0.7, see Table 3 [41, 42].
Fifty separate subjects completed the questionnaire
for the test–retest method to examine the reliability of
the questionnaire. The questionnaire was administered
twice, two weeks apart, at the same time of day, with
no change to their daily routines or general circumstances between testing. The test–retest reliability of
the questionnaire was determined by calculating the
ICC. Results can be seen in Table 3. All scores
exceeded 0.7 which is the desired criteria to be met
[44].
An assumption of the test–retest reliability assessment is that a subject’s condition remains stable between the first test and the retest, as no intervention
took place. This is evident from the strong ICC value
seen for symptom score of 0.893. Taking this into
consideration, a post hoc ICC was performed to
compare the repeatability of the symptom score after
two weeks of treatment in the ongoing interventional
treatment study. It was expected that the correlation
would be much weaker, as subjects’ symptoms should
have changed after receiving treatment. This hypothesis was confirmed with an ICC = 0.655 \ 0.893. A
two-tailed t-test was applied to both sets of data. There
was no significant difference in total symptom score in
the test–retest group (P = 0.536) in comparison to a
highly significant difference in retest total symptom
score in the group that received treatment
(P = 0.000). Treatments included were; Dr. Organic
Tea Tree Face Wash, OcuSoft Plus lid scrubs and a
once off treatment with BlephEx followed by nightly
lid scrubs using OcuSoft Plus. The placebo effect of
receiving treatment must be taken into consideration
when assessing how effective treatments are at
improving symptoms. However, for the purpose of
assessing the questionnaires ability to measure change
in subjective symptoms, the placebo effect is considered extraneous.
The receiver operator characteristic (ROC) curve
was plotted to evaluate the diagnostic ability of the
symptom questionnaire to assess for the presence of
DF. A relatively flat ROC curve was formed, with an
area under the curve (AUC) of 0.614 (Fig. 1). A
positive symptom result C G1 gives a sensitivity of
70.8% and a specificity of 46.9% for the questionnaire.
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Table 2 Factor analysis was applied to the modified OSDI questionnaire
Factor
Ocular symptoms

Vision related function

Environmental triggers

0.373

- 0.233

Factor analysis
Dryness

0.534

Gritty/irritated

0.696

Itchy

0.636

Red eyes

0.546

Burning

0.403

Photophobia

0.342

Watery

0.614

Lids stuck together

0.209

Reading

0.722

Night driving

0.518

Computer

0.745

Television

0.499

0.244

0.246

0.610
0.277

Wind

0.886

Cold air
Air conditioning

0.230
0.220

Extraction method: principal axis factoring
Rotation method: oblimin with Kaiser normalization
Kaiser–Meyer–Olkin measure of sampling adequacy: 0.784
Results show 3 subscales similar to OSDI; Ocular Symptoms, Vision Related Function, Environmental Triggers. Burning sensation,
discomfort in cold air and discomfort in air conditioned environments loaded on more than one factor. This is likely due to the
multifactorial nature of dry eye and common crossover between symptoms and causes

Table 3 Reliability analysis: Cronbach’s a measuring internal consistency, and ICC measuring repeatability for the questionnaire
Internal consistency: Cronbach’s a (95%
confidence interval) (n = 156)

Test–retest: Intra-class Correlation Co-efficient (95%
confidence interval) (n = 50)

Reliability of the symptom questionnaire
Ocular symptoms

0.741

Vision related function

0.795

0.824
0.725

Environmental triggers

0.825

0.887

Symptom
questionnaire as a
whole

0.839

0.897

Results are shown for each of the subscales and for the overall questionnaire as a whole. All values were [ 0.7

As expected, as severity of symptoms increase (G3
severe symptoms), the sensitivity drops to 33%, but
the specificity increases to 85.7%.
Questionnaire application
One hundred and fifty-six subjects completed the
questionnaire and were assessed for presence and

quantity of DF. The overall prevalence of DF found
was 68%. The total mean number of DF found per
subject on microscopic examination was 3.83 mites
(range 0–25). Subjects included 70 males and 86
females with a mean age of 45.98 ± 18.36 years
(range 19–82 years). The presence and quantity of DF
was not significantly different between genders
(P = 0.061 and P = 0.695, respectively). Females,
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1

71
70

0.8
0.7

60
54

0.6
0.5

Percentage

True positive rate (Sensitivity)

0.9

0.4
0.3
0.2

50

46

40

Asymptomatic
Symptomatic

29

30

0.1
0

20

0

0.2

0.4

0.6

0.8

1

False positive rate (1 - Specificity)

10

Fig. 1 ROC curve demonstrates the ability of the novel
questionnaire to assess for presence of DF using symptom
grade (Normal—Severe: 0–3). AUC = 0.614

however, were more symptomatic (P = 0.026)
(Table 4). The presence of DF was significantly
associated with increasing age (t-test; P = \ 0.001).
Likewise, the quantity of DF was significantly associated with increasing age also (rs 0.386;
P = \ 0.001).
Presence of Demodex folliculorum
versus symptoms
Subjects with DF were more symptomatic than those
without DF (X2; P = 0.04) (Fig. 2). As such, the total
modified symptom score was significantly higher in
subjects with DF (25.01 ± 18.86) in comparison to
subjects without DF (18.81 ± 15.55) (MWU;
P = 0.05). Likewise, the severity of symptoms
increased in subjects with DF in comparison to
subjects without DF (X2; P = 0.028) (Fig. 3). The
greatest difference was found in the severe symptom
group. Very few (n = 7) subjects without DF had
severe symptoms (Fig. 3). The majority of subjects
without DF were asymptomatic. By comparison, the
majority of subjects with DF had symptoms; the

0
No DF

DF

Presence of Demodex folliculorum

Fig. 2 Percentage frequency distribution of symptomatic and
asymptomatic subjects, with and without DF. Subjects with DF
were significantly more symptomatic (X2; P = 0.04)

majority of which were severely symptomatic
(n = 35) (Fig. 3).
The prevalence of each symptom reported by
subjects with and without DF is shown in Table 5.
The presence of the symptom itch was significantly
associated with the presence of DF. A symptom of
‘itchy eyes’ was more commonly reported by subjects
with DF than those without (69 vs. 52%) (X2;
P = 0.025). The severity of itch for the presence of
DF was not found to be significant (X2; P = 0.131).
Overall subjects with ‘itchy eyes’ were not significantly older than those without ‘itchy eyes’ (MWU;
P = 0.826). Subject’s with ‘itchy eyes’ and DF were
significantly older than those with ‘itchy eyes’ and no
DF (MWU; P = \ 0001). Asymptomatic individuals
with DF were also older, but not significantly (MWU;
P = 0.323).
A functional vision symptom of ‘discomfort watching television’ was also significantly associated with

Table 4 Comparison of age, presence and quantity of DF, and OSDI scores for male and female study participants’
Sex

N

Age (years)

Prevalence (%)

Demodex count

OSDI score

Male

70

44.83 ± 18.03

74.29

4.02 (range 0–22)

19.54 ± 15.69

Female

86

46.93 ± 18.69

62.79

3.69 (range 0–25)

25.87 ± 19.39

P = 0.477 (A)

P = 0.126 (B)

P = 0.695 (A)

P = 0.026 (A)
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predisposed to an increase in presence of DF given
the significant risk factor that age is for DF [15, 46].

50
46
45
40

Percentage

35

33

Quantity of Demodex folliculorum
versus symptoms

29

30

24

25

22

20

18
14

15

14

10
5
0

Asymptomatic

Mild

Moderate

Severe

Symptoms
No DF

DF

Fig. 3 Percentage frequency distribution of grade of severity of
symptoms among subjects with and without DF (X2;
P = 0.028). 46% of subjects without DF were asymptomatic
and only 14% had severe symptoms. Only 29% of subjects with
DF were asymptomatic, however, 33% had severe symptoms. It
is also evident that the majority of symptomatic subjects with
DF were severely symptomatic

the presence of DF (42 vs. 12%) (X2; P = 0.000).
However, overall subjects reporting ‘discomfort when
watching television’ were significantly older than
those without any discomfort (MWU; P = 0.010). As
the symptomatic group is older, they will be

The total mean number of DF found per subject on
microscopic examination was 3.83 mites (range 0–25).
Not all subjects with DF were symptomatic. The mean
number of mites found was significantly higher among
symptomatic subjects (4.53 mites: range 0–25) in
comparison to asymptomatic subjects (2.51 mites:
range 0–19) (MWU; P = 0.021). Spearman’s correlation showed no significant relationship between
quantity of DF and the modified OSDI score
(rs = 0.122; P = 0.128). However, a low positive
correlation was established between the number of DF
mites and increasing grade of severity of symptoms
(rs = 0.162; P = 0.0439). This correlation is
expressed in the equation: Y = 0.0267 X (number of
DF) ? 1.2565, and suggests that on average 1 DF
mite = G1.28 symptoms. An increase of 28 more
mites is required to produce moderate symptoms, and
a further 38 extra (minimum 66 mites) required to
produce severe symptoms. Spearman’s correlation
demonstrated an equation similar to above,
Y = 0.0264 X (number of DF) ? 1.0552, that an
increase in severity of ‘itchy eyes’ was also positively
associated with an increase in the quantity of DF

Table 5 Prevalence of symptoms reported by subjects with and without DF; given as percentage of subjects in each group
Symptom

Subjects with Demodex folliculorum (%)

Subjects without Demodex folliculorum (%)

P value (X2)

Gritty/irritated

72

70

0.685

Itchy

69

52.0

0.025

Dryness
Wind

68
57

68
62

0.880
0.459

Air conditioning

55

44

0.251

Watery

53

60

0.347

Photophobia

45

46

0.959

Red eyes

45

40

0.378

Computer

43

40

0.656

Cold air

43

30

0.167

Problems reading

42

36

0.300

Television

42

12

0.000

Burning sensation

28

18

0.137

Lids stuck together

21

12

0.184

Night driving

19

8

0.063
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(rs = 0.172; P = 0.035). Likewise, this equation
suggests that 1 DF = G1.08 (‘itchy eyes’ some of
the time), but on average, an increase of a further 36
DF mites, respectively, are required to produce
respective increases in severity of symptoms. Thus,
the above equations for severity of symptoms and
severity of itch show that the presence of just 1 DF can
produce mild symptoms, but symptoms can also be
present without DF, as seen previously.
An increase in severity of ‘discomfort when
watching television’ was found to be significantly
associated with an increase in quantity of DF
(rs = 0.164; P = 0.044). Further analysis showed
that this increase was directly parallel to an increasing
age for the same symptom (rs = 0.24; P = 0.003).
Given the low overall prevalence (32%) of ‘discomfort when watching television’, even among subjects
with DF, and the significant increase in age of those
symptomatic, it is possible that age-related dry eye
changes may be contributing to this symptom. However, presence and quantity of DF should still be
considered as it is an age-related change, and very few
control subjects reported discomfort.
Time of day did not appear to affect symptoms with
respect to DF. No other individual symptom was found
to be significantly associated with the presence or
quantity of DF.
Pathogenic infestation
Earlier studies have suggested not all incidence of DF
is pathogenic, and it appears to be an increase in
quantity of DF that causes ‘‘pathogenic’’ infestation
[47, 48]. Using the severity scale suggested by Randon
et al. [48], C 3 mites per follicle, data was analysed to
look at the prevalence of ‘‘pathogenic’’ DF in the study
population, and any associations between ‘‘pathogenic’’ DF infestation and age and symptoms
(Table 6).
Subjects with ‘‘pathogenic’’ DF infestation were
significantly older than subjects with ‘‘non-pathogenic’’ DF infestation (MWU; P = 0.014) and subjects with no DF (MWU; P \ 0.001). Subjects with
‘‘non-pathogenic’’ DF infestation were older, but not
significantly, than subjects with no DF (MWU;
P = 0.067).
Subjects with ‘‘pathogenic’’ and ‘‘non-pathogenic’’
DF were more symptomatic than subjects with no DF,
although this difference was not found to be significant
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for either group (MWU; P = 0.076 and P = 0.118,
respectively). The highest prevalence of the symptom
‘itchy eyes’ was among subjects with ‘‘pathogenic’’
DF, however, when compared to subjects with no DF,
this was not significant (X2; P = 0.077).

Discussion
Demodex folliculorum is commonly associated with
ocular surface disease [7]. The prevalence of DF
reported in the literature varies from 20 to 100%,
increasing with age and existing presence of ocular
surface disease. Kemal et al. [49] found a prevalence
of 28.8% in blepharitis subjects and 26.7% among
normal individuals. Gao et al. [11] reported a prevalence of 100% among patients with CD, and 22%
among patients without CD. Kabataş et al. [22]
discovered a prevalence of 67.2% in blepharitis
patients and 54.9% in control patients. Roth [46]
reported an overall prevalence of 84% that increased
to 100% in subjects over 70 years of age. Lee et al.
[36] found an overall prevalence of 70% in their
demographic epidemiology study. The present study,
in good agreement with previous studies, found an
overall prevalence of 68% which was higher in older
and in symptomatic subjects.
The current study discovered a relatively high
prevalence of DF, even among normal population.
However, there is an ongoing debate over the
pathogenicity of the ectoparasites [7, 50–52]. The
findings in this study are in agreement with previous
authors [53, 54], that DF can be found among
asymptomatic individuals. The present study found
an overall mean number of 2.51 mites (range 0–19)
among asymptomatic individuals. Lacey et al. [52]
suggested that in many cases DF is a mere commensal
organism with possible beneficial roles—ingesting
bacteria and other micro-organisms in the lash follicle.
Forton et al. [55] demonstrated in dermatology that
\ 5 mites/cm2 is considered normal, and that higher
densities are seen in the presence of disease or
immunodeficiency. Baima et al. [50] postulated that
the mite has the potential to become pathogenic to the
host where numbers of mites increase beyond a critical
level. Randon et al. [48] suggest this level as C 3 mites
per follicle. The increase in symptoms, as seen in
previous studies [15, 22, 23, 36] and in the current
study also, would suggest that DF does have
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Table 6 Comparison of quantity of DF, age, presence of symptoms, modified OSDI score, and presence of itch for subjects with; no
DF, mild ‘‘non-pathogenic’’ infestation, and ‘‘pathogenic’’ infestation of DF. A = Kruskal–Wallis P value: B = X2 P value
Frequency
(n) (Prevalence
%)

Quantity of
mites
(mean ± SD)

Age (yrs)
(mean ± SD)

Presence of
Symptoms
(%)

Modified
OSDI
(mean ± SD)

Presence
of Itch (%)

No Demodex folliculorum

50 (32%)

0.00 ± 0.00

37.76 ± 17.02

54.00

18.81 ± 15.55

52.00

Mild/Normal infestation (\ 3
mites per follicle)
Pathogenic infestation (C 3
mites per follicle)

39 (25%)

1.54 ± 0.68

44.62 ± 19.07

64.10

25.79 ± 19.49

66.67

60 (38.5%)

8.97 ± 5.20

53.60 ± 16.51

75.00

24.02 ± 17.33

71.67

7 (4.5%)

0.00 ± 0.00

47.14 ± 14.36

71.43

29.27 ± 28.79

57.14

\ 0.001 (A)

0.141 (B)

0.274 (A)

Mites visible on lash
manipulation but not on
microscope

pathogenic potential as the numbers of DF present an
increase. Furthermore, in an ongoing study, these
symptoms were shown to be improving following
treatment, thus strengthening the argument that the DF
mites do have pathogenic potential. Se˛dzikowska et al.
[23] recently published results of a large-scale study
investigating the association between DF and presence
of symptoms reported by patients without the use of a
questionnaire. The results propose that a minimum of
7 DF mites per 8 epilated eyelashes is required to
produce 1 symptom, and that a further 18 mites are
required to produce a second symptom. In the study
conducted by Se˛dzikowska et al. [23], they did not
measure severity of these symptoms reported by
patients: intermittent vs constant, sometimes vs all of
the time, merely the presence of the symptom. The
current study investigated the severity of symptoms
reported by patients using a modified version of the
OSDI questionnaire. Applying a similar statistical
analysis as that applied by Se˛dzikowska et al. [23], the
current study found a much higher number (33) of DF
was required to produce moderate symptoms. While
the results of both studies show good agreement, they
are not directly comparable, as the current study
counted DF mites on 4 epilated eyelashes, whereas
Se˛dzikowska et al. [23] counted DF mites on 8
epilated eyelashes.
Symptoms can be present in the absence of DF, and
similarly DF can be present in the absence of
symptoms. A prevalence of 68% DF was found in
the current study. Of these affected individuals, only
71% (75/106) had symptoms, (X2; P = 0.028)

0.161 (B)

(Fig. 2). A potential reason for this is that chronic
inflammation of the anterior ocular surface can lead to
changes in corneal morphology [56], leading to
corneal hypoesthesia, thus resulting in reduced symptoms in the presence of severe infestation and inflammation [57–59]. As a result, patient reported
symptoms do not always correlate well with clinical
signs of ocular surface disease, as was demonstrated in
the current study. While it appears that the majority of
individuals with DF have symptoms; nonetheless,
asymptomatic individuals can also have DF. As such,
this study found that among those 106 individuals with
DF, the quantity of DF seen on microscopic examination was similar between asymptomatic and symptomatic subjects (4.39 ± 4.37 mites vs 6.16 ± 5.82
mites, respectively; MWU; P = 0.185). A potential
cause for this could be that chronic infestation and
inflammation has resulted in hypoesthesia at the ocular
surface resulting in an asymptomatic subject with
large numbers of DF. However, as DF reside in the
follicle, the crawling, scrapping movement of the
mites would be expected to create an itching sensation,
which should not be affected by corneal hypoesthesia.
A more likely possibility is that not all DF was
removed during lash epilation. During the study, it
became apparent that especially in cases where lashes
were loose in damaged lash follicles due to the
presence of high numbers of DF, the lash would slip
out leaving the DF still inside the lash follicle. This
further enhances the need to combine symptoms and a
thorough clinical work-up when screening and treating
patients for DF. It should be taken into consideration
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when assessing for the presence of DF that as the
severity of infestation increases, the looser the lashes
become. This increases the possibility of DF mites
remaining in the lash follicles. The authors recommend using lash manipulation in combination with
epilation to accurately assess the severity of DF
infestation. Further research into the benefit of lash
manipulation is currently taking place and will be
described in more detail in a future paper.
The literature reports certain symptoms commonly
associated with DF; itch, burning sensation, foreign
body sensation, redness and crusts along the lid
margins, blurred vision and misdirection of eyelashes
[7, 15, 22, 23, 60–62]. Ocular dryness (74.7%), itching
(42.78%), and irritation (39.1%) were reported in a
study by Koo et al. [15]. Kabataş et al. [22] stated
prevalence values of symptoms of redness (80%),
itching (63.6%) and foreign body sensation (55.6%) in
DF positive blepharitis patients. Se˛dzikowska et al.
[23] reported similar symptoms but lower values:
itching (28%), redness (21%), watery eyes (15%), and
dryness (6%) among others. The use of specific
questionnaires was not discussed by Kabataş et al.
[22] or Se˛dzikowska et al. [23]. The lower prevalence
values reported in the study by Se˛dzikowska et al. [23]
are likely as a result of symptom reporting not being
prompted by the use of a questionnaire; but depended
on each subject complaining of a symptom of their
own accord. The most commonly reported symptoms
by subjects with DF in the current study were gritty
irritated eyes (72%) followed by; itch (69%), dryness
(68%), watery (57%), photophobia (45%), red eyes
(45%), burning sensation (28%), and lids stuck
together (21%). Many of these symptoms were also
commonly reported by subjects that did not have any
DF, and were not found to be significantly associated
with DF. However, in agreement with previous studies
[22, 23, 62], the current study found that the symptom
‘itchy eyes’ was associated with an increased presence
of DF. Furthermore, the current study demonstrated
that the severity of ‘itchy eyes’ increased as the
number of DF increased. This further strengthens the
basis for ‘itchy eyes’ as a significant symptom of DF
infestation.
It should be noted that the symptom ‘itchy eyes’
was also reported by approximately 50% of the control
subjects, this was not unexpected. Dry eye is multifactorial and its symptoms are subjective, and therefore can be interpreted differently by each individual.
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For example, itch is one of the hallmark symptoms of
allergy. Data collection for the current study took
place over 2 years, therefore, it is possible that a
history of allergy influenced the severity of the
symptom itch. However, Chi square analysis showed
no significant correlation between the presence of
allergy and the presence of general symptoms, or
symptoms of itch among subjects that did not have DF
(X2; P = 0.79 and P = 0.085, respectively). The
authors are not suggesting ‘itchy eyes’ as a diagnostic
symptom of DF; merely that it appears to be a more
prevalent and frequently reported symptom among
individuals affected with DF infestation. Potentially,
the presence of the symptom itch is as an allergic
response to the presence of DF which has been
hypothesised previously [7, 63].
The OSDI questionnaire is one of the most commonly used symptom questionnaires administered to
subjects in DF related clinical trials [15, 35, 36].
Results from the present study and previous studies
outlined above have demonstrated that itch is amongst
the most common complaint in subjects with DF.
However, no question on the original OSDI exists to
ask about ‘itchy eyes’. The modified questionnaire
developed by Lee et al. [36] included a question on
‘itchy eyes’, and demonstrated that the overall OSDI
score was significantly associated with increased
numbers of DF. Nonetheless, the authors of the current
study were unable to infer if the questionnaire
modified and administered by Lee et al. [36] had been
validated and therefore would suggest the utilisation
of the current questionnaire, or similar validated
questionnaire (that includes questions regarding itchy
eyes) in future studies relating to DF.

Conclusion
The novel questionnaire demonstrated good internal
consistency (Cronbach’s a was [ 0.7 for both the total
questionnaire and each of the subscales) and good to
very good repeatability ([ 0.75) for both the total
questionnaire and each of the subscales in the test–
retest ICC. The strong repeatability component of the
questionnaire shows that it can be used as a valid
means of monitoring patient’s subjective symptoms as
a result of treatment over time in a clinical setting.
This is becoming increasingly more important as

Int Ophthalmol (2019) 39:405–417

PROs become a critical part of patient-centred management in the health sector [26].
The questionnaire displayed a reasonable sensitivity value of 70.8% for correctly identifying subjects
found positive for DF infestation. However, for
verifying the presence of DF infestation and knowing
who requires further intervention, this would not be
sufficient and indicates that a thorough clinical workup would also be required to confirm diagnosis.
To the best of the authors’ knowledge, this is the
first study that has looked at the prevalence of ocular
DF and its associated symptoms in an Irish population.
There was a strong link between the presence and
quantity of DF and severity of symptoms, using the
modified OSDI questionnaire. Itch was significantly
associated with the presence of DF above any other
symptom reported by patients. In clinical practice, it is
important to remember the presence of DF in patients
complaining of itchy eyes. Based on the findings of the
current study, it would be advisable to utilise the
current questionnaire or a questionnaire that includes
questions about itch when managing and treating
anterior ocular disorders such as blepharitis. However,
a thorough clinical work-up is still required for
differential diagnosis between various anterior ocular
disorders.
Not all patients with DF will be symptomatic, even
when infestation is seemingly severe. As with many
anterior ocular disorders, symptoms can be similar and
may not always be present. The relationship between
DF infestation and corneal hypoesthesia needs to be
investigated further and additional research into the
triggers that cause a patient to become symptomatic is
still required.
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57. Hoşal BM, Örnek N, Zilelioğlu G, Elhan AH (2005) Morphology of corneal nerves and corneal sensation in dry eye:
a preliminary study. Eye 19:1276–1279
58. Bourcier T, Acosta MC, Borderie V et al (2005) Decreased
corneal sensitivity in patients with dry eye. Investig Ophthalmol Vis Sci 46:2341
59. Lemp MA, Baudouin C, Baum J et al (2007) The definition
and classification of dry eye disease: report of the definition
and classification subcommittee of the international dry eye
work shop (2007). Ocul Surf 55:75–92

417
60. Gao YY, Di Pascuale MA, Elizondo A, Tseng SC (2007)
Clinical treatment of ocular demodicosis by lid scrub with
tea tree oil. Cornea 26:136–143
61. Kheirkhah A, Casas V, Li W et al (2007) Corneal manifestations of ocular Demodex infestation. Am J Ophthalmol
143:743–749
62. Kojima T, Ishida R, Sato EA et al (2011) In vivo evaluation
of ocular demodicosis using laser scanning confocal
microscopy. Investig Ophthalmol Vis Sci 52:565–569
63. Georgala S, Katoulis AC, Kylafis GD et al (2001) Increased
density of Demodex folliculorum and evidence of delayed
hypersensitivity reaction in subjects with papulopustular
rosacea. J Eur Acad Dermatol Venereol 15:441–444

123

